Skip to search formSkip to main contentSkip to account menu

MIR363 gene

Known as: MIR363, hsa-mir-363, MIR-363 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract TMP31: Mir363 Treatment Improves Depressive-Like Behavioral Phenotype and Rescues Retrograde Degeneration of Meso-Striatal Projections in Middle-Aged Female Rats
2018
2018
Effect of miR-363 on the proliferation, invasion and apoptosis of laryngeal cancer by targeting Mcl-1.
OBJECTIVE To investigate the potential effect of miR-363 on the development of laryngeal cancer and to reveal the relevant… 
2018
2018
Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression
In multiple myeloma, abnormal plasma cells accumulate and proliferate in the bone marrow. Recently, we observed that Runx2, a… 
2017
2017
Abstract 2525: Targeting myeloma cell-derived runx2 by miRNAs suppresses multiple myeloma growth and progression
In Multiple myeloma (MM), abnormal plasma cells accumulate in the bone marrow and spread to new bone sites. However, the… 
2017
2017
Abstract LB-323: Comparative miRNA microarray profiling indicates miR-363 promotes chemoresistance in ovarian cancer cells by targeting the Hippo member, LATS2
Ovarian cancer is the most aggressive female reproductive tract tumours. Taxane (TX) is widely used for ovarian cancer treatment… 
2016
2016
Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells.
BACKGROUND The miR-106a-363 cluster, encoding six miRNAs (miR- 106a, miR-18b, miR-20b, miR-19b-2, miR-92-2 and miR-363), has been… 
Highly Cited
2014
Highly Cited
2014
Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.
Gastric carcinoma is one of the most common malignancies and the second most lethal cancer worldwide. The mechanisms underlying… 
2014
2014
Award Number: W81XWH-11-1-0491 TITLE: Role of MicroRNA in Aggressive Prostate Cancer PRINCIPAL INVESTIGATOR: Hsieh, Jer-Tsong CONTRACTING ORGANIZATION: University of Texas, Southwestern Medical…
2013
2013
Abstract 5295: DysregulatedmiR-363affects head and neck cancer invasion and metastasis by targetingPDPNgene.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Head and neck squamous cell carcinoma (HNSCC) is… 
2010
2010
gastrointestinal tumors 709 PD FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II / III GASTRIC CANCER PATIENTS AFTER CURATIVE D 2…
741P CON + Gem (Arm 1) AMG 479 + Gem (Arm 2) Pbo + Gem (Arm 3) Arm 1 vs 3 Arm 2 vs 3 6-mo OS (95% CI)* 59% (42, 73) 57% (41, 70… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)